“…The functions of many proteins are controlled by ubiquitination [3,4], and in cancer cells, abnormal ubiquitination may promote the activity of oncogenic pathways [5,6], enhance tumour proliferation, migration, invasion, angiogenesis, epithelial-mesenchymal transition and metastasis [7,8]. Kelch-like family member 7 (KLHL7), which is a member of the Kelch protein family associated with the development of retinitis pigmentosa [9,10], forms a ubiquitin ligase complex by binding to the BTB and BACK domains of Cullin3 (CUL3) [10,11]. This binding facilitates proteasome degradation of target proteins by enhancing E2 or E3 ligase activity and polyubiquitination [10][11][12].…”